share_log

12 Health Care Stocks Moving In Thursday's Pre-Market Session

Benzinga ·  Oct 31 20:09

Gainers

  • Autonomix Medical (NASDAQ:AMIX) shares moved upwards by 50.8% to $15.44 during Thursday's pre-market session. The company's market cap stands at $17.7 million.
  • Tenon Medical (NASDAQ:TNON) shares moved upwards by 34.96% to $4.4. The company's market cap stands at $2.4 million.
  • Aerovate Therapeutics (NASDAQ:AVTE) shares rose 25.56% to $2.75. The market value of their outstanding shares is at $79.3 million.
  • Alphatec Holdings (NASDAQ:ATEC) shares increased by 24.73% to $7.01. The market value of their outstanding shares is at $984.6 million. As per the press release, Q3 earnings came out yesterday.
  • Envista Holdings (NYSE:NVST) stock increased by 14.4% to $22.0. The company's market cap stands at $3.7 billion. As per the press release, Q3 earnings came out yesterday.
  • Madrigal Pharmaceuticals (NASDAQ:MDGL) shares moved upwards by 13.46% to $245.0. The market value of their outstanding shares is at $5.3 billion. The company's, Q3 earnings came out today.

Losers

  • Matinas BioPharma Hldgs (AMEX:MTNB) shares fell 51.8% to $0.93 during Thursday's pre-market session. The market value of their outstanding shares is at $4.6 million.
  • Equillium (NASDAQ:EQ) stock decreased by 42.76% to $0.79. The market value of their outstanding shares is at $27.9 million.
  • Ensysce Biosciences (NASDAQ:ENSC) shares decreased by 21.34% to $0.5. The market value of their outstanding shares is at $7.4 million.
  • CalciMedica (NASDAQ:CALC) stock declined by 19.8% to $3.85. The company's market cap stands at $41.3 million.
  • Psyence Biomedical (NASDAQ:PBM) shares declined by 19.15% to $0.08. The market value of their outstanding shares is at $4.1 million.
  • Compass Pathways (NASDAQ:CMPS) shares fell 16.81% to $5.15. The market value of their outstanding shares is at $352.1 million. As per the news, the Q3 earnings report came out today.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment